QCMC
CRL icon

Quantum Capital Management (California)’s Charles River Laboratories CRL Stock Holding History

Quantum Capital Management (California)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$157K Sell
697
-174
-20% -$36.1K 0.18% 84
2020
Q2 		$152K Sell
871
-327
-27% -$52.2K 0.09% 126
2020
Q1 		$151K Sell
1,198
-111
-8% -$16.6K 0.1% 137
2019
Q4 		$200K Sell
1,309
-176
-12% -$24.4K 0.1% 138
2019
Q3 		$197K Buy
+1,485
New +$199K 0.1% 150

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quantum Capital Management (California)'s CRL Position: Q3 2020 in Review

Quantum Capital Management (California) reduced its Charles River Laboratories (CRL) stake by 20% in Q3 2020, selling an estimated $36.1K and leaving 697 shares worth $157K. The position accounts for 0.18% of the portfolio, ranked #84.

Quantum Capital Management (California) first reported a position in CRL in Q3 2019 and has held it in 5 quarters since. The position peaked at $200K in Q4 2019. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • Quantum Capital Management (California) held 697 shares of Charles River Laboratories worth $157K as of Q3 2020.
  • Quantum Capital Management (California) sold 174 Charles River Laboratories shares in Q3 2020, an estimated $36.1K.
  • Charles River Laboratories made up 0.18% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #84 holding.
  • Quantum Capital Management (California) first reported a position in Charles River Laboratories in Q3 2019 and has held it in 5 quarters since.
  • Quantum Capital Management (California)'s Charles River Laboratories position peaked at $200K in Q4 2019.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.